The role of record linkage in post-marketing drug surveillance.
作者信息
Crombie I K
出版信息
Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):77S-82S. doi: 10.1111/j.1365-2125.1986.tb02987.x.
Abstract
摘要
相似文献
1
The role of record linkage in post-marketing drug surveillance.记录链接在上市后药品监测中的作用。
Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):77S-82S. doi: 10.1111/j.1365-2125.1986.tb02987.x.
2
Postmarketing drug surveillance by record linkage in Tayside.泰赛德地区通过记录链接进行的药品上市后监测。
J Epidemiol Community Health. 1984 Sep;38(3):226-31. doi: 10.1136/jech.38.3.226.
3
EDPS of clinical case record and scientific document in the industry post-marketing surveillance of drugs.药品上市后监测行业中临床病例记录和科学文献的电子数据处理系统
Methods Inf Med. 1983 Jul;22(3):135-48.
4
Record linkage for postmarketing surveillance.用于上市后监测的记录链接
Clin Pharmacol Ther. 1989 Oct;46(4):479-80. doi: 10.1038/clpt.1989.169.
5
[Drug surveillance. Monitoring the side-effects of drugs in the post-marketing phase: cimetidine. II].[药物监测。上市后阶段药物副作用的监测：西咪替丁。II]
Clin Ter. 1984 Apr 30;109(2):109-25.
6
The role of automated record linkage in the postmarketing surveillance of drug safety: a critique.自动记录链接在药品安全性上市后监测中的作用：一项批判性分析。
Clin Pharmacol Ther. 1989 Oct;46(4):371-86. doi: 10.1038/clpt.1989.154.
7
Record linkage studies for postmarketing drug surveillance: data quality and validity considerations.上市后药品监测的记录链接研究：数据质量与有效性考量
Drug Intell Clin Pharm. 1988 Feb;22(2):157-61. doi: 10.1177/106002808802200216.
8
Post-marketing surveillance of new drugs.新药上市后监测
J R Coll Gen Pract. 1987 Aug;37(301):337-8.
9
Therapeutic auditing at the national and international level.国家和国际层面的治疗性审计。
Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):55S-59S. doi: 10.1111/j.1365-2125.1986.tb02983.x.
10
Uninformed criticism of automated record linkage.对自动化记录链接的盲目批评。
Clin Pharmacol Ther. 1989 Oct;46(4):478-9. doi: 10.1038/clpt.1989.168.
引用本文的文献
1
Classifying Drug Ratings Using User Reviews with Transformer-Based Language Models.使用基于Transformer的语言模型通过用户评论对药物评级进行分类
Proc (IEEE Int Conf Healthc Inform). 2022 Jun;2022:163-169. doi: 10.1109/ichi54592.2022.00035. Epub 2022 Sep 8.
2
Post-marketing surveillance in the UK (1984).英国的上市后监测（1984年）。
Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):71S-75S. doi: 10.1111/j.1365-2125.1986.tb02986.x.
本文引用的文献
1
Peptic ulcer: the changing scene.消化性溃疡：不断变化的情况。
Scott Med J. 1981 Oct;26(4):297-302. doi: 10.1177/003693308102600402.
2
Record linkage for drug monitoring.用于药物监测的记录链接。
J Epidemiol Community Health. 1981 Mar;35(1):25-31. doi: 10.1136/jech.35.1.25.
3
Vaginal spermicides and congenital disorders.阴道用杀精剂与先天性疾病
JAMA. 1981 Apr 3;245(13):1329-32.
4
Postmarketing surveillance of adverse drug reactions in general practice. I: search for new methods.全科医疗中药物不良反应的上市后监测。I：探寻新方法。
Br Med J (Clin Res Ed). 1981 Apr 4;282(6270):1131-2. doi: 10.1136/bmj.282.6270.1131.
5
Postmarketing drug surveillance by record linkage in Tayside.泰赛德地区通过记录链接进行的药品上市后监测。
J Epidemiol Community Health. 1984 Sep;38(3):226-31. doi: 10.1136/jech.38.3.226.
6
Postmarketing surveillance of adverse reactions to drugs.药品不良反应的上市后监测。
Br Med J (Clin Res Ed). 1984 Mar 24;288(6421):879-80. doi: 10.1136/bmj.288.6421.879.
7
Medicaid drug-event data: an emerging tool for evaluation of drug risk.
Acta Med Scand Suppl. 1984;683:127-34. doi: 10.1111/j.0954-6820.1984.tb08728.x.
8
9
Screening criteria for drug monitoring. The Kaiser-Permanente drug reaction monitoring system.
J Chronic Dis. 1972 Jan;25(1):11-20. doi: 10.1016/0021-9681(72)90017-3.
10
Sample size requirements in cohort and case-control studies of disease.队列研究和疾病病例对照研究中的样本量要求。
Am J Epidemiol. 1974 Jun;99(6):381-4. doi: 10.1093/oxfordjournals.aje.a121625.
Zotero 插件